Vision and the hypothalamus

Optometry

Volumn 81, Issue 2, 2010, Pages 100-115

  Trachtman, Joseph N ^a  

^a Elite Performance and Learning Center PS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEGENERATIVE DISEASE; HISTOLOGY; HISTORY; HUMAN; HYPOTHALAMUS; NEUROLOGY; OPHTHALMOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; VISION; VISUAL SYSTEM;

HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HYPOTHALAMUS; NEURODEGENERATIVE DISEASES; NEUROLOGY; OPHTHALMOLOGY; RETINA; VISION, OCULAR; VISUAL PATHWAYS;

EID: 75449114068     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2009.07.016     Document Type: Article

References (178)

1. nd ed (2007), Lippincott, Williams & Wilkins, Philadelphia
2. Amonoo-Kuofi H.S. Horner's syndrome revisited: With an update of the central pathway. Clin Anat 12 5 (1999) 345-361
3. Lechan RM, Toni R. Functional anatomy of the hypothalamus and pituitary. Available at: www.Endotext.com. Last accessed November 6, 2008.
4. Swaab D.F. The human hypothalamus: Basic and clinical aspects. Part I: Nuclei of the human hypothalamus (2003), Elsevier, Amsterdam
5. Alquier T., and Kahn B.B. Peripheral signals set the tone for central regulation of metabolism. Endocrinology 145 9 (2004) 4022-4024
6. McEwen B.S., and Lasley E.N. Stress and emotional connection. The end of stress as we know it (2002), Joseph Henry Press, Washington, D.C.
7. Morgan M.W. The nervous control of accommodation. Am J Optom 21 (1944) 87-93
8. Morgan M.W. A new theory for the control of accommodation. Am J Optom 23 (1946) 99-110
9. Kasai T., Unno M., Fujii K., et al. Dynamic characteristics of human eye accommodation system. Proceedings of Osaka University. Japan No. 1014 (1971) 569-586
10. Hurwitz B.S., Davidowitz J., Chin N.B., et al. The effects of the sympathetic nervous system on accommodation. I. Beta sympathetic nervous system. Arch Ophthalmol 87 (1972) 668-674
11. Garner L.F., Brown B., Baker R., et al. The effect of phenylephrine hydrochloride on the resting point of accommodation. Invest Ophthalmol Vis Sci 24 4 (1983) 393-395
12. Gilmartin B., Hogan R.E., and Thompson S.M. The effect of timolol maleate on tonic accommodation, tonic convergence, and pupil diameter. Invest Ophthalmol Vis Sci 25 6 (1984) 763-770
13. Gilmartin B., and Hogan R.E. The relationship between tonic accommodation and ciliary muscle innervation. Invest Ophthalmol Vis Sci 26 7 (1985) 1024-1028
14. Stephens K.G. Effect of sympathetic nervous system of accommodation. Am J Optometry 62 6 (1985) 402-406
15. Mordi J.A., Lyle W.M., and Mousa G.Y. Effect of phenylephrine on accommodation. Am J Optometry 63 4 (1986) 294-297
16. Bullimore M.A., and Gilmartin B. Tonic accommodation, cognitive demand, and ciliary muscle innervation. Am J Optometry 64 1 (1987) 45-50
17. Lubkin V., Bezai P., and Sadun A.A. The eye as a metronome of the body. Surv Ophthalmol 47 1 (2002) 17-26
18. Cannon W.B. The wisdom of the body. Rev. ed (1939), W.W. Norton, New York
19. Bernard C. An introduction to the study of experimental medicine (1957), Dover Publications (Reprint edition), New York
20. Selye H. Stress and disease. Science 122 3171 (1955) 625-631
21. Miller N.E. The learning of visceral and glandular responses. Science 163 (1969) 434-445
22. Stark L., and Takahashi Y. Absence of an odd-error signal mechanism in human accommodation. IEEE Transactions in Bio-Medical Engineering 12 3-4 (1965) 138-146
23. Miller N.E. Neal E. Miller: Selected papers (1971), Aldine-Atherton, New York
24. Berntson G.G., Cacioppo J.T., and Quigley K.S. Autonomic determinism: The modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Physiological Rev 98 4 (1991) 459-487
25. Pert C.B., and Snyder S.H. Properties of opiate-receptor binding in rat brain. Proc Natl Acad Sci 70 8 (1973) 2243-2247
26. Guillemin R. Peptides in the brain. The new endocrinology of the neuron. Nobel Lecture December 8, 1977 (1977). http://nobelprize.org/nobelfoundation/publications/lectures/index.html Available at: http://nobelprize.org/nobelfoundation/publications/lectures/index.html. Last accessed December 17, 2009.
27. Schally A.V. Aspects of hypothalamic regulation of the pituitary gland with major emphasis on its implications for the control of reproductive processes. Nobel Lecture (December 8, 1977)
28. Snyder S.H. Brain peptides as neurotransmitters. Science 209 4460 (1980) 976-983
29. Moncada S. Nitric oxide: Discovery and impact on clinical medicine. J Royal Soc Med 92 (1999) 164-169
30. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (1992) 3051-3064
31. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 2 (1991) 109-142
32. Denef C. Paracrinicity: The story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol 20 1 (2008) 1-70
33. Netter F. The Ciba collection of medical illustrations, Volume I, nervous system (1964), Ciba, New York
34. In: Schmidt R.F. (Ed). Fundamentals of neurophysiology. 3rd Revised Edition (1985), Springer-Verlag, New York
35. th ed. (2004), Churchill Livingstone, London
36. Brain S.D., and Cox H.M. Neuropeptides and their receptors: Innovative science providing novel therapeutic targets. Br J Pharmacol 147 (2006) S202-S211
37. von Euler U.S., and Gaddum J.H. An unidentified depressor substance in certain tissue extracts. J Physiol 72 (1931) 74-87
38. Lembeck F. Central transmission of afferent impulses. III. Incidence and significance of the substance P in the dorsal roots of the spinal cord. Naunyn Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 219 3 (1953) 197-213
39. Isaacs A., and Lindenmann J. Virus interference: the interferon. Proc Royal Soc London B 147 (1957) 258
40. Baron S., and Isaacs A. Absence of interferon in lungs from fatal cases of influenza. Br Med J (1962) January 6:18-20
41. Isaacs A. Antiviral action of interferon. Br Med J (1962) August 11: 353-5
42. 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacycglycerols and the calcium ionophore A23187. Proc Natl Acad Sci USA 84 (1987) 3663-3667
43. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
44. Simon H.B. Hyperthermia. N Engl J Med 329 (1993) 483-487
45. Delves P.J., Roitt I.M., Martin S.J., et al. Roitt's essential immunology (2006), Blackwell Publishing, Malden, MA
46. Kreuger J.M., and Majde J.A. Microbial products and cytokines in sleep and fever regulation. Crit Rev Immunol 14 304 (1994) 355-379
47. Cameron E, May P. Nitrous oxide-Laughing gas. School of Chemistry, University of Bristol, 2008. Available at: www.chm.bris.ac.uk/motm/n2o/n2oj.htm. Last accessed December 17, 2009.
48. Barañano D.E., and Snyder S.H. Neurol roles of heme oxygenase: Contrast to nitric oxide synthase. Proc Natl Acad Sci 98 20 (2001) 10996-11002
49. Stefano G.B., Friccione G.L., Slingsby B.T., et al. The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Res Rev 35 (2001) 1-19
50. Hess W. The central control of the activity of the internal organs. Nobel Prize in Physiology or Medicine 1949, Nobel Lecture, December 12, 1949. Available at: http://nobelprize.org/nobelfoundation/publications/lectures/index.html. Last accessed December 17, 2009.
51. Assenmacher I., Szafarczyk A., Alonso G., et al. In: Ganong W.F., Dallman M.F., and Roberts J.L. (Eds). The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci. Physiology of neural pathways affecting CRH secretion Volume 512 (1987), The New York Academy of Sciences, New York 149-161
52. Negro-Vilar A., Johnston C., Spinedi E., et al. In: Ganong W.F., Dallman M.F., and Roberts J.L. (Eds). The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci. Physiological role of peptides and amines on the regulation of ACTH secretion Volume 512 (1987), The New York Academy of Sciences, New York 218-236
53. Thompson R.C., Seasholtz A.F., Douglass J.O., et al. In: Ganong W.F., Dallman M.F., and Roberts J.L. (Eds). The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci. The rat corticotropin-releasing hormone gene Volume 512 (1987), The New York Academy of Sciences, New York 1-11
54. Barnes P.J. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 94 (1998) 557-572
55. Augustin A.J., D'Amico D.J., Mieler W.F., et al. Safety of posterior juxtascleral depot administration of the angiostatic cortisone anecortave acetate for treatment of subfoveal chroidal neovascularization in patients with age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 243 (2005) 9-12
56. Dahlin D.C., and Rahimy M.H. Pharmacokinetics and metabolism of anecortave acetate in animals and humans. Surv Ophthalmol 52 Suppl 1 (2007) S49-S61
57. Russell S.R., Hudson H.L., and Jerdan J.A. Anecortave acetate for the treatment of exudative age-related macular degeneration-A review of clinical outcomes. Surv Ophthalmol 52 Suppl 1 (2007) S79-S90
58. Clark A.F. Introduction. Surv Ophthalmol 52 Suppl 1 (2007) S1-S2
59. Robin A.L., Suan E.P., Sjaarda R.N., et al. Arch Ophthalmol 127 2 (2009) 173-178
60. De Souza E.B., Whitehouse P.J., Price D.L., et al. In: Ganong W.F., Dallman, and Roberts J.L. (Eds). The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci. Abnormalities in corticotrophin-releasing hormone (CRH) in Alzheimer's disease and other human disorders Volume 512 (1987), The New York Academy of Sciences, New York 237-247
61. Yehuda R., Golier J.A., Halligan S.L., et al. The ACTH response to desamethasone in PTSD. Am J Psychiatry 161 (2004) 1397-1403
62. Bjartell A., Ekman R., Sundler F., et al. In: Ganong W.F., Dallman M.F., and Roberts J.L. (Eds). The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci. Delta sleep-inducing peptide-like immunoreactivity in pituitary ACTH/MSH and adrenal medullary cells Volume 512 (1987), The New York Academy of Sciences, New York 476-479
63. McCann S.M., Antunes-Rodrigues J., Franci C.R., et al. Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection. Brazilian Journal of Medical and Biological Research 33 (2000) 1121-1131
64. Hauger R.L., Risbrough V., Brauns O., et al. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS & Neurological Disorders - Drug Targets 5 4 (2006) 453-479
65. Ostrander M.M., Ulrich-Lai Y.M., Choi D.C., et al. Hypoactivity of the hypothalamic-pituitary-adrenocortical axis during recovery from chronic variable stress. Endocrinology 147 4 (2006) 2008-2017
66. Lucin K.M., Sanders V.M., Jones T.B., et al. Impaired antibody synthesis after spinal cord injury is level-dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 207 1 (2007) 75-84
67. Sternberg E.M. Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens. Nat Rev Immunol 64 4 (2006) 318-328
68. Irwin M.R. Human psychoneuroimmunolgy: 20 years of discovery. Brain, Behavior, and Immunity 22 (2008) 129-139
69. Town A.E., and Rakoff A.E. Relationship of endocrines to cataract. Trans Am Ophthalmol Soc 48 (1950) 313-330
70. Duke-Elder S. The clinical value of cortisone and ACTH in ocular disease. Br J Ophthalmol 35 (1951) 637-671
71. Anderson B., and Margolis G. Scleromalacia: Clinical and pathologic study of a case with consideration of differential diagnosis, relationship of collagen disease, and effect of ACTH and cortisone therapy. Trans Am Ophthalmol Soc 49 (1951) 235-265
72. Brown C.A., and Corner B. Retrolental fibroplasias: Early development and the effect of ACTH in treatment. Br J Ophthalmol 36 (1952) 281-302
73. Appelbaum A. Retrolental fibroplasias: Blindness in infants of low weight at birth. California Med 77 4 (1952) 259-265
74. Thompson M., and Eadie S. Kerato-conjunctivitis sicca and rheumatoid arthritis. Ann Rheumatism 15 (1956) 21-25
75. Toogood J.H., Dyson C., Thompson C.A., et al. Posterior subcapsular cataracts as a complication of adrenocortical steroid therapy. Can Med Assoc J 86 (1962) 52-56
76. Kaiser-Kupfer M.I. Clinical research methodology in ophthalmology. Trans Am Ophthalmol Soc 78 (1980) 896-46
77. Zoukhri D. Effect of inflammation of lacrimal gland function. Exp Eye Res 82 5 (2006) 885-898
78. Swaab D.F. The human hypothalamus: Basic and clinical aspects. Part II: Neuropathology of the human hypothalamus and adjacent structures (2003), Elsevier, Amsterdam
79. Sadun A.A., Schaechter J.D., and Smith L.E. A retinohypothalamic pathway: Light mediation of circadian rhythms. Brain Res 302 2 (1984) 371-377
80. Schaechter J.D., and Sadun A.A. A second hypothalamic nucleus receiving retinal input in man: The paraventricular nucleus. Brain Res 340 2 (1985) 243-250
81. Kenney M.J., Weiss M.L., and Haywood J.R. The paraventricular nucleus: An important component of the central neurocircuitry regulating sympathetic nerve outflow. Acta Physiologica Scand 177 1 (2003) 7-15
82. Sadun A.A., Johnson B.M., and Schaechter J. Neuroanatomy of the human visual system: Part III: Three retinal projections to the hypothalamus. Neuro-ophthalmology 6 6 (1986) 371-376
83. In: Kastin A.J. (Ed). Handbook of biologically active peptides (2006), Academic Press, Burlington, MA
84. Lumme A., Vanhatalo S., Sadeniemi M., et al. Expression of nitric oxide synthase in hypothalamic nuclei following axonal injury or colchinine treatment. Exp Neurol 144 2 (1997) 248-257
85. Hypothalmus. Available at. www.neuroanatomy.wisc.edu/coursebook/neuro2(2).pdf Last accessed December 17, 2009
86. Terakita A. The opsins. Genome Biology 6 3 (2005) 213/1-213/9
87. Wald G., and Brown P.K. The synthesis of rhodopsin from retinene. Proc Natl Acad Sci 36 (1950) 84-92
88. Wald G. The molecular basis of visual excitation. Nobel Lecture, December 12, 1967. Available at: http://nobelprize.org/nobelfoundation/publications/lectures/index.html. Last accessed December 17, 2009.
89. Bowmaker J.K., and Dartnall H.J.A. Visual pigments of rods and cones in a human retina. J Physiol 298 (1980) 501-511
90. Provencio I., Rodriguez I.R., Jiang G., et al. A novel human opsin in the inner retina. J Neurosci 20 2 (2000) 600-605
91. Hannibal J., Hindersson P., Knudsen S.M., et al. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 22 (2002) RC191 1-7
92. Provencio I., Jiang G., De Grip W.J., et al. Melanopsin: An opsin in melanophores, brain, and eye. Proc Natl Acad Sci 95 (1998) 240-245
93. Vesaluoma M., Teppo A.-N., Grönhagen-Riska C., et al. Increased release of tumour necrosis factor-α in human tear fluid after excimer lazer induced corneal wound. Br J Ophthalmol 81 (1997) 145-149
94. Tuominen I., Vesaluoma M., Teppo A.-N., et al. Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomy. Br J Ophthalmol 83 (1999) 360-363
95. Yamada M., Ogata M., Kawai M., et al. Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 43 8 (2002) 2622-2625
96. Creel D.J., Bendel C.M., Wiesner G.L., et al. Abnormalities of the central visual pathways in Parder-Willi syndrome associated with hypopigmentation. N Engl J Med 314 (1986) 1606-1609
97. Daley M.I., and Cook D. Impaired visual flicker discrimination with hypothalamic pituitary disease. Arch Neurol 40 (1983) 643-644
98. Klaver C.C.W., Ott A., Hofman A., et al. Is age-related maculopathy associated with Alzheimer's disease?: The Rotterdam Study. Am J Epidemol 150 9 (1999) 963-968
99. Bayer A.U., Ferrari F., and Erb C. High occurrence rate of glaucoma among patients with Alzeimer's disease. Eur Neurol 47 3 (2002) 165-168
100. Bayer A.U., Keller O.N., Ferrari F., et al. Association of glaucoma with neurogenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133 1 (2002) 135-137
101. Cooper H.M., Parvopassu F., Herbin M., et al. Neuroanatomical pathways linking vision and olfaction in mammals. Psychoneuroendocrinology 19 5-7 (1994) 623-639
102. Kauffmann D.J.H., van Meurs J.C., Mertens D.A.E., et al. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative viteroretinopathy. Invest Ophthalmol Vis Sci 35 3 (1994) 900-906
103. Ooi K.G.-J., Galatowicz G., Calder V.L., et al. Cytokines and chemokines in uveitis-Is there a correlation with clinical phenotype?. Clin Med Res 4 4 (2006) 294-309
104. Tarrant T.K., Silver P.B., Wahlsten J.L., et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis. J Exp Med 189 2 (1999) 219-230
105. Stone R.A., and McGlinn A.M. Calcitonin gene-related peptide immunoreactive nerves in human and rhesus monkey eyes. Invest Ophthalmol Vis Sci 29 2 (1988) 305-310
106. Riise D., and Simonsen S.E. Intraocular pressure in unilateral optic nerve lesion. Acta Ophthalmologica 47 3 (1969) 750-756
107. Paulsen F., Hallmann U., Paulsen J., et al. Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat 197 (2000) 177-187
108. Dieckhues V.B. The influence of eyesight on organ and metabolic function in man and animal. Hippokrates 45 4 (1974) 433-449
109. Vervloed M.P.J., Hoevenaars E., and Maas A. Behavioral treatment of sleep problems in a child with a visual impairment. J Vis Impair Blindness 97 (2003) 28-37
110. Ionescu D., Driver H.S., Heon E., et al. Sleep and daytime sleepiness in retinitis pigmentosa patients. J Sleep Res 10 (2001) 329-335
111. Gordo M.A., Recio J., and Sánchez-Barceló E.J. Decreased sleep quality in patients suffering from retinitis pigmentosa. J Sleep Res 10 (2001) 159-164
112. Gebarowska D., Stitt A.W., Gardiner T.A., et al. Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization. Am J Pathol 160 1 (2002) 307-313
113. Tornqvist K., and Ehinger B. Peptide immunoreactive neurons in the human retina. Invest Ophthalmol Vis Sci 29 5 (1988) 680-686
114. Available at: www.rxlist.com. Last accessed December 17, 2009.
115. Grus F.H., Podust V.N., Bruns K., et al. SELDI-TOF-MS Proteinchip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 46 3 (2005) 863-876
116. Available at: www.biology-online.org/dictionary/Paracrine. Last accessed December 17, 2009.
117. Dinan T.G., and Scott L.V. Anatomy of melancholia: Focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. J Anat 207 (2005) 259-264
118. Potter E., Behan D.P., Linton E.A., et al. The central distribution of a corticotrophin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci 89 (1992) 4192-4196
119. Henriksen G., and Willoch F. Imaging of opioid receptors in the central nervous system. Brain 131 (2008) 1171-1196
120. Clark K.A., Shin A.C., Sirivelu M.P., et al. Systemic administration of leptin decreases plasma corticosterone levels. Brain Res 1195 (2008) 89-95
121. Available at: http://braininfo.rprc.washington.edu/. Last accessed December 17, 2009.
122. Curristin S.M., Cao A., Stewart W.B., et al. Disrupted synaptic development in the hypoxic newborn brain. Proc Natl Acad Sci 99 24 (2002) 15729-15734
123. Nadler J.V., Tu B., Timofeeva O., et al. Neuropeptide Y in the recurrent mossy fiber pathway. Peptides 28 2 (2007) 357-364
124. Coveñas R., Martin F., Belda M., et al. Mapping of neurokinin-like immunoreactivity in the human brainstem. BMC Neuroscience 4 (2003) 3-15
125. Crocker A., España R.A., Papadopoulou M., et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65 8 (2005) 1184-1188
126. Qin L., He J., Hanes R.N., et al. J Neuroinflammation 5 (2008) 10-26
127. Taheri S., and Hafizi S. The orexins/hypocretins: Hypothalamic peptides linked to sleep and appetite. Psychol Med 32 (2002) 955-958
128. Kar S., Slowikowski S.P.M., Westaway D., et al. Interactions between β-amyloid and central cholinergic neurons: Implications for Alzheimer's disease. J Psychiatry Neurosci 29 6 (2004) 427-441
129. Simantov R., Kuhar M.J., Uhl G.R., et al. Opioid peptide enkephalin: Immunohistochemical mapping in rat nervous system. Proc Natl Acad Sci 74 5 (1977) 2167-2171
130. Denton D.A., McKinley M.J., and Weisinger R.S. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci 93 (1996) 7397-7404
131. Pelletier G., and Desy L. Localization of ACTH in the human hypothalamus. Cell Tiss Res 196 3 (1979) 525-530
132. Available at: www.neuroanatomy.wisc.edu/coursebook/neuro2(2).pdf. Last accessed December 17, 2009.
133. Lightman S.L. The neuroendocrine paraventricular hypothalamus: Receptors, signal transduction, mRNA and neurosecretion. J Exp Biol 139 (1988) 31-49
134. De Lecea L., Kilduff T.S., Peyron C., et al. The hypocretins: Hypothalamus-specific peptides with neuroexicitatory activity. Proc Natl Acad Sci 95 (1998) 322-327
135. Rechtshaffen A., and Siegel J. Sleep and dreaming. In: Kandel E.R., Schwartz J.H., and Jessel T.M. (Eds). Principles of neuroscience. Fourth ed (2000), McGraw-Hill, New York 936-947
136. Elmquist J.K., Ahima R.S., Elias C.F., et al. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci 95 (1998) 741-746
137. Saarela S., and Reiter R.J. Function of melatonin in thermoregulatory processes. Life Sci 54 5 (1994) 295-311
138. Hofman M.A., Fliers E., Goudsmit E., et al. Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: Sex differences and age-dependent changes. J Anat 160 (1988) 127-143
139. Kramer K.M., Yoshida S., Papademetriou E., et al. The organizational effects of oxytocin on the central expression of estrogen receptor α and oxytocin in adulthood. BMC Neurosci 8 (2007) 71-78
140. Sakai K., Agassandian K., Morimoto S., et al. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest 117 4 (2007) 1088-1095
141. Hammock E.A.D., and Young L.J. Oxytocin, vasopressin and pair bondings: Implications for autism. Philos Trans Royal Soc 361 (2006) 2187-2198
142. Trottier S., Chotard C., Traiffort E., et al. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Res 939 91-2 (2002) 52-64
143. Levin B. Orexins: neuropeptides for all seasons and functions. Am J Physiol Regul Integr Comp Physiol 291 (2006) R885-R888
144. Bear M.F., Conners B.W., and Paradiso M.A. Neuroscience: Exploring the brain. ed3. (2006), Lippincott, Williams and Wilkins, Philadelphia
145. Brothers L. Biological perspectives on empathy. Am J Psychiatry 146 1 (1989) 10-19
146. Myagkov A.V., Danilov G.E., and Fatykhov I.R. The correcting influence of the locus coeruleus on ophthalmic hypertension of hypothalamic origin. Neurosci Behav Physiol 34 1 (2004) 97-100
147. American College of Obstericians and Gynecologists (ACOG) Committee on Technical Bulletins. American College of Obstetricians and Gynecologists Technical Bulletin 1989;134:1-5.
148. Yamada K., Yamamoto H., Nakagawa Y., et al. Etiology of idiopathic scoliosis. Clin Orthop 184 (1984) 50-57
149. Greidanus R.Bv.W., Jolles J., and De Wied D. Hypothalamic neuropeptides and memory. Acta Neurochirugica 75 1-4 (1985) 99-105
150. Koroshetz W.J., and McKee A.C. Case records of the Massachusetts General Hospital: Case 39-1988: A 76-old man with confusion, agitation, and a gait disorder. N Engl J Med 319 13 (1988) 849-860
151. D'Amore P.A., and Klagsbrun M. Endothelial cell mitogens derived from retina and hypothalamus: Biochemical and biological similarities. J Cell Biol 99 (1984) 1545-1549
152. Seckl J., and Dunger D. Postoperative diabetes insipidus. Br Med J 298 6665 (1989) 2-3
153. Byrd J.A. Controversy in scoliosis treatment - symposium: Current theories on the etiology of idiopathic scolisis. Clin Orthopaed Related Res 229 (1988) 114-119
154. Werntz D.A. Cerebral hemispheric activity and autonomic nervous function. Dissertation Abstracts International (1981) DAI V42(06), SECB, PP2255
155. Gribenski A. Sensory interactions: Hearing and vision. J de Psychologie Normale et Pathologique 75 2 (1978) 147-171
156. Zhu J.N., Yung W.H., Chow B.K.C., et al. The cerebellar-hypothalamic circuits: Potential pathways underlying cerebellar involvement in somatic-visceral integration. Brain Res Rev 52 1 (2006) 93-106
157. Smeets P.A.M., deGraaf C., Stafleu A., et al. Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr 82 (2005) 1011-1016
158. Witta J., Palkovits M., Rosenberger J., et al. Distribution of nociceptin/orphannin FQ in adult human brain. Brain Res 997 1 (2004) 24-29
159. Hollwich F., Dieckhues B., and Schrameyer B. Die Wirkung des natürlichen und künstlichen Lichtes über das Auge den Hormon- und Stoffwechsel-haushalt des Menschen. Klinische Monatblatter für Augenheilkunde 171 1 (1877) 98-104
160. Aizman O., Uhlén P., Lal M., et al. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc Natl Acad Sci 98 23 (2001) 13420-13424
161. Slominski A., Wortsman J., Kohn L., et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol 119 6 (2002) 1449-1455
162. Poole C.J.M., and Lightman S.L. Inhibition of vasopressin secretion during migraine. J Neurol Neurosurg Psychiatry 51 (1988) 1441-1444
163. Spinazzi R., Andreis P.G., Rossi G.P., et al. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 58 1 (2006) 46-57
164. Bannister R. Autonomic disorders. Curr Opin Neurol 1 4 (1988) 511-513
165. Eckland D., and Lightman S. The hypothalamus. Curr Opin Neurol 1 4 (1988) 527-532
166. Ling H., Vamvakas S., Busch G., et al. Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells. Am J Physiol Renal Physiol 269 (1995) F911-F917
167. Molavi DW. Hypothalomus and autonomic nervous system. The Washington University School of Medicine. Available at: http://thalamus.wustl.edu/course/hypoANS.html. Last accessed December 17, 2009.
168. Öngür D., and Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex 10 3 (2000) 206-219
169. Pizzi J, Holden JE. Lateral hypothalamus modifies pain through a substance P connection with the periaqueductal gray. Presented at the Midwest Nursing Research Society, Cincinnati, April 1-4, 2005.
170. Paulson D.F., Wiebe H.R., and Hammond C.B. Hypothalamic and pituitary function in hypogonadotropic hypogonadism. Urology 6 3 (1975) 333-336
171. Kaiser U.B., Sabbagh E., Katzenellenbogen R.A., et al. A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone. Proc Natl Acad Sci 92 (1995) 12280-12284
172. Delmas A., Leone M., Rousseau S., et al. Clinical review: Vasopressin and terlipressin in septic shock. Crit Care 9 2 (2005) 212-222
173. Bissonette B., Sessler D.I., and LaFlamme P. Intraoperative temperature monitoring sites in infants and children and the effect of inspired gas warming on esophageal temperature. Anesth Analg 69 (1989) (30):192-6
174. Komisaruk B.R., Whipple B., Crawford A., et al. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res 1024 1-2 (2004) 77-88
175. Berger J. Why do circadian biorhythms age?. J Appl Biomed 1 (2003) 77-84
176. Wartofsky L., Martin D., and Earll J.M. Alterations in thyroid iodine release and the peripheral metabolism of thyroxine during acute falciparum malaria in man. J Clin Invest 51 (1972) 2215-2232
177. The brain. Available at: www.emc.maricopa.edu/./BIOBK/brain_3.gif. Last accessed December 17, 2009.
178. Hormone control: the hypothalomus. Available at: http://www.psycheducation.org/emotion/hypothalamus.htm. Last accessed December 17, 2009.